6,7,8,9-tetrahydro-3h-pyrazolo[4,3-f] isoquinoline compound useful in the treatment of cancer

PK144920APending Publication Date: 2026-11-05ASTRAZENECA AB
0 Cites 0 Cited by

Patent Information

Application Number
PK201700519
Authority / Receiving Office
PK · PK
Patent Type
Applications
Current Assignee / Owner
Filing Date
2017-10-06
Publication Date
2026-11-05
Patent Text Reader

Abstract

The specification relates to compound of Formula (I): to process and for their preparation, to pharmaceutical composition containing them and the treatment of cell proliferative disorders.
Need to check novelty before this filing date? Find Prior Art